Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders
18 nov. 2024 08h00 HE
|
Psychemedics Corporation
Psychemedics Corporation reminds its stockholders to vote ahead of the Company’s upcoming annual meeting of stockholders scheduled for November 25, 2024.
Psychemedics Corporation Reports Third Quarter 2024 Financial Results
12 nov. 2024 16h05 HE
|
Psychemedics Corporation
DALLAS, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, today announced financial results for the third...
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing
26 sept. 2024 09h00 HE
|
Psychemedics Corporation
Psychemedics Corporation, a global leader in hair testing for drugs of abuse, announces the release of its first-ever Education Insights Report.
Psychemedics Corporation Launches New Ketamine Hair Testing Service
29 août 2024 09h00 HE
|
Psychemedics Corporation
Psychemedics Corporation, a global leader in hair testing, announces the launch of its new ketamine hair testing solution.
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
13 août 2024 16h05 HE
|
Psychemedics Corporation
DALLAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, today announced financial results for the second...
Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock
12 août 2024 16h12 HE
|
Psychemedics Corporation
DALLAS, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) (“Psychemedics” or the “Company”) today announced that a Transaction Committee (the “Transaction Committee”) of the...
Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing
21 juin 2024 10h00 HE
|
Psychemedics Corporation
Psychemedics Corporation releases its inaugural 2024 Insights Report, offering a comprehensive analysis of workplace drug trends from 2023.
Psychemedics Corporation Reports First Quarter 2024 Financial Results
14 mai 2024 16h55 HE
|
Psychemedics Corporation
DALLAS, May 14, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, today announced financial results for the first...
Psychemedics Corporation Reports 2023 Financial Results
28 mars 2024 08h20 HE
|
Psychemedics Corporation
DALLAS, March 28, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, announced today financial results for the year...
Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider
21 mars 2024 09h00 HE
|
Psychemedics Corporation
Psychemedics Corporation announces its recognition as one of the Top 10 Employee Health Testing Services Providers for 2024 by ManageHR